THYROTAIN Trademark

Trademark Overview

On Tuesday, October 20, 2020, a trademark application was filed for THYROTAIN with the United States Patent and Trademark Office. The USPTO has given the THYROTAIN trademark a serial number of 90267130. The federal status of this trademark filing is REGISTERED as of Tuesday, October 12, 2021. This trademark is owned by Ortho Molecular Products, Inc.. The THYROTAIN trademark is filed in the Pharmaceutical Products category with the following description:

Nutritional supplements
thyrotain

General Information

Serial Number90267130
Word MarkTHYROTAIN
Filing DateTuesday, October 20, 2020
Status700 - REGISTERED
Status DateTuesday, October 12, 2021
Registration Number6522258
Registration DateTuesday, October 12, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Goods and ServicesNutritional supplements

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 2, 2020
Primary Code005
First Use Anywhere DateTuesday, January 1, 2002
First Use In Commerce DateTuesday, January 1, 2002

Trademark Owner History

Party NameOrtho Molecular Products, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBarrington, IL 60010
Party NameOrtho Molecular Products, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoodstock, IL 60098
Party NameOrtho Molecular Products, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoodstock, IL 60098

Trademark Events

Event DateEvent Description
Friday, October 23, 2020NEW APPLICATION ENTERED
Wednesday, December 2, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 15, 2021ASSIGNED TO EXAMINER
Sunday, March 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 9, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 3, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, August 3, 2021USE AMENDMENT FILED
Friday, August 13, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, August 13, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 8, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 12, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, February 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 14, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, August 14, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 14, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 14, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

thyrotain supplements nutritional